Chapter 11. Today's Science, Tomorrow's Patient: the Pivotal Role of Tissue, Clinical Data and Informatics in Modern Drug Development
- Sylvia Nagl
Published Online: 16 MAY 2006
DOI: 10.1002/0470032898.ch11
Copyright © 2006 John Wiley & Sons, Ltd
Book Title

Cancer Bioinformatics: From Therapy Design to Treatment
Additional Information
How to Cite
Knox, K., Taylor, A. and Kerr, D. J. (2006) Today's Science, Tomorrow's Patient: the Pivotal Role of Tissue, Clinical Data and Informatics in Modern Drug Development, in Cancer Bioinformatics: From Therapy Design to Treatment (ed S. Nagl), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/0470032898.ch11
Editor Information
Department of Oncology, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, UK
Publication History
- Published Online: 16 MAY 2006
- Published Print: 27 JAN 2006
ISBN Information
Print ISBN: 9780470863046
Online ISBN: 9780470032893
- Summary
- Chapter
Keywords:
- National Cancer Research Institute (NCRI);
- NCRI National Cancer Tissue Resource (NCTR);
- NCTR central bioinformatics platform;
- proposed information system architecture;
- e-Government Interoperability Framework (e-GIF)-compliant clinical information system;
- NCRI Informatics Strategic Framework;
- Multi-centre Research Ethics Committee (MREC);
- consent and confidentiality
Summary
This chapter contains sections titled:
Introduction
A new national strategy for the provision of tissue annotated with clinical information to meet current and future needs of academic researchers and industry
The NCRI National Cancer Tissue Resource for cancer biology and treatment development
A potential future world-class resource integrating research and health service information systems and bioinformatics for cancer diagnosis and treatment
A proposed information system architecture that will meet the challenges and deliver the required functionality: an overview
Consent and confidentiality: ensuring that the NCTR is embedded in the UK's legal and ethical framework
Concluding remarks: future challenges and opportunities
